Clinical trial
Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's…
NCT00153972 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00153972 |
|---|---|
| Title | Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease |
| Official title | Dopamine Turnover Rate Measured With F-Dopa-PET as Surrogate Parameter for Diagnosis and Progression Analysis of Early Parkinson's Disease |
| Lead sponsor | Technische Universität Dresden, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Cabergoline, Levodopa |
| Enrollment | 39 |
| Start date | Feb 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 18, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: